So, Aris, how can you help me?
Can you make a PPT on the topic Colinger carcinoma that will be presented in the classroom by a second-year MBBS student in a proper way so that a teacher will get remarks as very good?
Cholangiocarcinoma bile duct cancer classification pathology clinical features treatment MBBS
Cholangiocarcinoma MBBS
Presentation · PPTX
| # | Slide | Highlights |
|---|---|---|
| 1 | Title Slide | Deep navy background, gold accent, professional presenter block |
| 2 | Table of Contents | 12 topic cards, two-column layout |
| 3 | Introduction & Definition | What is CCA, epidemiology basics |
| 4 | Epidemiology | Two-column: US stats vs global/geographic data |
| 5 | Etiology & Risk Factors | Three card columns: Parasitic, Biliary, Metabolic + mnemonic "CHIPS" |
| 6 | Classification | Intrahepatic, Perihilar (Klatskin), Distal with % frequency; Bismuth-Corlette note |
| 7 | Pathogenesis | Visual flow-box diagram + molecular drivers (IDH1/2, FGFR2, KRAS, TP53) |
| 8 | Morphology & Histopathology | Gross + microscopic features; real Robbins pathology image embedded |
| 9 | Clinical Features | Three-column by location: intrahepatic, perihilar, distal |
| 10 | Diagnosis & Investigations | Labs, Imaging, Tissue Diagnosis — three card columns |
| 11 | TNM Staging | Full AJCC 8th edition table (T/N/M + overall stages) |
| 12 | Treatment | Surgical, Palliative, Systemic (Gem-Cis + durvalumab TOPAZ-1 trial) |
| 13 | Prognosis | Survival table by type + poor prognostic factors |
| 14 | Differential Diagnosis | 6 key differentials with distinguishing clues |
| 15 | Recent Advances | Targeted therapy table: FGFR2, IDH1, HER2, NTRK, PD-L1 |
| 16 | Key Points | 10 numbered exam-important takeaways |
| 17 | References | Robbins, Sleisenger, NEJM papers (TOPAZ-1, ivosidenib, pemigatinib) |
| 18 | Thank You | Dark elegant closing slide |
Thank u